TAM
Tocqueville Asset Management Portfolio holdings
AUM
$6.55B
This Quarter Return
+3.43%
1 Year Return
+21.88%
3 Year Return
+89.23%
5 Year Return
+153.22%
10 Year Return
+366.25%
AUM
$6.06B
AUM Growth
+$6.06B
(-1%)
Cap. Flow
+$71.3M
Cap. Flow
% of AUM
1.18%
Top 10 Holdings %
Top 10 Hldgs %
28.49%
Holding
554
New
20
Increased
118
Reduced
256
Closed
29
Top Buys
| 1 |
Biogen
BIIB
|
$40.3M |
| 2 |
Apollo Global Management
APO
|
$24.5M |
| 3 |
Salesforce
CRM
|
$24M |
| 4 |
Home Depot
HD
|
$11.8M |
| 5 |
AbbVie
ABBV
|
$8.44M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$43.9M |
| 2 |
Bank of America
BAC
|
$32.7M |
| 3 |
Charles Schwab
SCHW
|
$24.7M |
| 4 |
Boeing
BA
|
$18.5M |
| 5 |
Warner Bros
WBD
|
$16.8M |
Sector Composition
| 1 | Technology | 22.85% |
| 2 | Consumer Discretionary | 11.67% |
| 3 | Healthcare | 11.35% |
| 4 | Industrials | 11.25% |
| 5 | Financials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Brown & Brown
BRO
$31.4B
| $208K | ﹤0.01% |
2,327
| – | – |
|
502
LyondellBasell Industries
LYB
$17.4B
| $207K | ﹤0.01% |
2,163
+18
| +0.8% | +$1.72K |
|
503
Hartford Financial Services
HIG
$37.4B
| $205K | ﹤0.01% |
2,036
-490
| -19% | -$49.3K |
|
504
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8B
| $204K | ﹤0.01% |
1,800
| – | – |
|
505
InterDigital
IDCC
$7.35B
| $204K | ﹤0.01% |
+1,750
| New | +$204K |
|
506
First Citizens BancShares
FCNCA
$25.7B
| $204K | ﹤0.01% |
121
-20
| -14% | -$33.7K |
|
507
Esperion Therapeutics
ESPR
$490M
| $172K | ﹤0.01% |
77,500
+37,750
| +95% | +$83.8K |
|
508
MeiraGTx Holdings
MGTX
$590M
| $169K | ﹤0.01% |
40,200
+700
| +2% | +$2.95K |
|
509
UNIFI
UFI
$80.2M
| $157K | ﹤0.01% |
26,666
| – | – |
|
510
LXP Industrial Trust
LXP
$2.66B
| $143K | ﹤0.01% |
15,679
| – | – |
|
511
Clarivate
CLVT
$2.79B
| $140K | ﹤0.01% |
24,625
-49,640
| -67% | -$282K |
|
512
3D Systems Corporation
DDD
$263M
| $136K | ﹤0.01% |
44,187
-14,148
| -24% | -$43.4K |
|
513
Tempest Therapeutics
TPST
$46.6M
| $89.2K | ﹤0.01% |
40,750
+26,750
| +191% | +$58.6K |
|
514
Enviri
NVRI
$894M
| $88K | ﹤0.01% |
10,200
-30,700
| -75% | -$265K |
|
515
Zymeworks
ZYME
$1.07B
| $87.7K | ﹤0.01% |
10,302
-838
| -8% | -$7.13K |
|
516
Lantern Pharma
LTRN
$46.3M
| $79.4K | ﹤0.01% |
17,000
-2,000
| -11% | -$9.34K |
|
517
Immix Biopharma
IMMX
$64M
| $74.8K | ﹤0.01% |
37,800
| – | – |
|
518
Cognition Therapeutics
CGTX
$174M
| $66.4K | ﹤0.01% |
40,000
+14,000
| +54% | +$23.2K |
|
519
OraSure Technologies
OSUR
$230M
| $63.9K | ﹤0.01% |
14,991
-98
| -0.6% | -$417 |
|
520
BioXcel Therapeutics
BTAI
$52.7M
| $56K | ﹤0.01% |
43,750
-4,500
| -9% | -$5.78K |
|
|
ARC
521
DELISTED
ARC Document Solutions, Inc.
ARC
| $48.8K | ﹤0.01% |
18,467
| – | – |
|
522
Televisa
TV
$1.51B
| $48.8K | ﹤0.01% |
17,600
-2,000
| -10% | -$5.54K |
|
523
Lloyds Banking Group
LYG
$63.7B
| $35.1K | ﹤0.01% |
+12,868
| New | +$35.1K |
|
524
Acurx Pharmaceuticals
ACXP
$6.56M
| $22.5K | ﹤0.01% |
10,000
| – | – |
|
525
Zevia
ZVIA
$198M
| $10.1K | ﹤0.01% |
15,000
| – | – |
|